Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).

Paolo GisondiAlice B GottliebBoni ElewskiMatthias AugustinSandy McBrideTsen-Fang TsaiChristine de la LogeFrederik FierensJosé M López PintoNicola TiltMark G Lebwohl

Published in: Dermatology and therapy (2022)

ClinicalTrials.gov NCT02326298 (CIMPASI-1) and NCT02326272 (CIMPASI-2).

Keyphrases

clinical trial
open label
coronary artery disease
study protocol
double blind
randomized controlled trial
case control
placebo controlled
newly diagnosed